A detailed history of Squarepoint Ops LLC transactions in Tenaya Therapeutics, Inc. stock. As of the latest transaction made, Squarepoint Ops LLC holds 206,416 shares of TNYA stock, worth $491,270. This represents 0.0% of its overall portfolio holdings.

Number of Shares
206,416
Previous 120,704 71.01%
Holding current value
$491,270
Previous $374,000 6.42%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$1.93 - $3.99 $165,424 - $341,990
85,712 Added 71.01%
206,416 $398,000
Q2 2024

Aug 14, 2024

BUY
$2.72 - $4.99 $151,819 - $278,521
55,816 Added 86.02%
120,704 $374,000
Q1 2024

May 15, 2024

SELL
$2.88 - $6.8 $232,148 - $548,127
-80,607 Reduced 55.4%
64,888 $339,000
Q4 2023

Feb 14, 2024

BUY
$1.73 - $3.39 $251,706 - $493,228
145,495 New
145,495 $471,000
Q4 2022

Feb 14, 2023

BUY
$1.68 - $3.19 $102,760 - $195,122
61,167 New
61,167 $122,000

Others Institutions Holding TNYA

About Tenaya Therapeutics, Inc.


  • Ticker TNYA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,364,700
  • Market Cap $98.4M
  • Description
  • Tenaya Therapeutics, Inc., a biotechnology company, discovers, develops, and delivers therapies for heart disease in the United States. It develops its products through cellular regeneration, gene therapy, and precision medicine platforms. The company is developing TN-201, an adeno-associated virus (AAV)-based gene therapy to address genetic hyp...
More about TNYA
Track This Portfolio

Track Squarepoint Ops LLC Portfolio

Follow Squarepoint Ops LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

News

Stay updated on Squarepoint Ops LLC with notifications on news.